R 3 is C 2 -C 6 alkyl, C 2 -C 6 alkenyl, C 1 -C 4 haloalkyl, optionally substituted C 3 -C 6 cycloalkyl, optionally substituted C 2 -C 7 heterocycloalkyl, optionally substituted C 6 -C 10 aryl, OR 6 , NR 5 R 6 , C(O)R 7 , CO 2 R 6 , C(O)NR 5 R 6 , N(R 5 )C(O)R 7 , N(R 5 )CO 2 R 7 , NHS(O) 2 R 7 , S(O) 2 NR 5 R 6 , or R 2 and R 3 together form an optionally substituted C 2 -C 7 heterocycloalkyl ring
10.1021/acsomega.8b00595 113 Van SpronsenM.HoogenraadC
HUBERMAN: For growth hormone releasing hormone, such that your system will no longer respond either to the Hexarelin or to any other peptide, or perhaps most importantly, to any endogenous, that is naturally made growth hormone, excuse me, releasing hormone that you would make
Maintenance dosing strategies Once you reach your target weight, your provider may recommend reducing the dose to a maintenance level rather than continuing at the full therapeutic dose